Nivolumab Induced Palmoplantar Keratoderma

QR Code

Nivolumab Induced Palmoplantar Keratoderma

Saved in:

Bibliographic Details
Main Authors:	Singamsetty Sushma, Kollipara Haritha, Gandikota Raghurama Rao, Sudhir Babu Karri
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-07-01
Series:	Indian Dermatology Online Journal
Online Access:	https://journals.lww.com/10.4103/idoj.idoj_422_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Case of Palmoplantar Keratodermas Complicated by Pseudoainhum and Literature Review
by: Ye J, et al.
Published: (2025-07-01)

Dupilumab Efficacy in Children with Palmoplantar Eczema
by: Nikolay N. Murashkin, et al.
Published: (2024-11-01)

Ustekinumab Efficacy in Children with Palmoplantar Psoriasis: Case Series
by: Maria A. Leonova, et al.
Published: (2024-11-01)

A Systematic Review on the Role of Desmoglein 1 and Desmoglein 3 in Etiopathogenesis and Metastasis of Oral Cancer
by: Pavan Kumar Yellarthi, et al.
Published: (2025-04-01)

Efficacy of a topical polyphenol-based formulation in palmoplantar psoriasis: an observational study
by: Simone Amato, et al.
Published: (2025-07-01)

Effective treatment of recalcitrant palmoplantar psoriasis in a patient with skin of color using bimekizumab
by: Emily G. Tocco, BS, et al.
Published: (2025-09-01)

Nivolumab in real-life clinical practice
by: M. A. Lyadova, et al.
Published: (2019-12-01)

Simpatectomía endoscópica transtorácica: opción terapéutica efectiva en la hiperhidrosis axilar y palmoplantar
by: Cristhian Hitler Cárdenas Toledo, et al.
Published: (2024-01-01)

Combined Use of Cabozantinib and Nivolumab in Clinical Practice
by: V. E. Askarov, et al.
Published: (2024-04-01)

Case Report: Successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome and palmoplantar pustulosis with ustekinumab
by: Luxia Chen, et al.
Published: (2025-07-01)

Transverse erythronychia – Transverse red band on finger nails: A unique nail change associated with palmoplantar dermatoses
by: Sindhu C. Bhaskaramenon, et al.
Published: (2025-01-01)

Childhood Linear Porokeratosis: A Rare Premalignant Dermatoses and its Unusual Palmoplantar Presentation – Two Cases with a Review
by: Harshita Shrivastava, et al.
Published: (2025-04-01)

Drug-associated abdominal aortitis and retroperitoneal fibrosis after treatment with nivolumab
by: Naomi Wedel, MD, BSc, et al.
Published: (2025-08-01)

Nivolumab monotherapy in metastatic colorectal cancer: current approaches to response evaluation
by: N. N. Babyshkina, et al.
Published: (2022-11-01)

CYFRA 21-1 predicts the efficacy of nivolumab in patients with advanced lung adenocarcinoma
by: Hiromichi Shirasu, et al.
Published: (2018-02-01)

Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell Carcinoma.
by: Witold Wiecek, et al.
Published: (2016-01-01)

Nivolumab for relapsed and refractory classical Hodgkin lymphoma: retrospective single center analysis
by: Magdalena Witkowska, et al.
Published: (2025-01-01)

Successful treatment of recurrent metastatic nasopharyngeal carcinoma with nivolumab: a case report
by: Yu. M. Bychkov, et al.
Published: (2019-07-01)

Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report
by: Koji Yasuda, et al.
Published: (2017-08-01)

Receptor occupancy assessment and interpretation in terms of quantitative systems pharmacology: nivolumab case study
by: Dmitry Shchelokov, et al.
Published: (2023-12-01)

Pathological complete response with nivolumab for recurrence of liver metastasis after gastrectomy of gastric cancer
by: Chen Jun, et al.
Published: (2023-05-01)

In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma
by: Liang JD, et al.
Published: (2025-06-01)

Colitis grave inmunomediada por Nivolumab-Ipilimumab: a propósito de un caso
by: Maria Victoria Foglino, et al.
Published: (2025-07-01)

Pharmacoeconomic analysis of therapy with brentuximab vedotin, nivolumab and pembrolizumab in patients with relapsed Hodgkin’s lymphoma
by: N. A. Avxentyev, et al.
Published: (2020-12-01)

Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report
by: Kuniyasu Takagi, et al.
Published: (2021-10-01)

A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration
by: Takahisa Yamaguchi, et al.
Published: (2021-12-01)

A clinical case of immune-mediated pneumonitis after nivolumab in a patient with Burkitt lymphoma
by: K. I. Utesheva, et al.
Published: (2023-03-01)

Extensive T-Cell Cutaneous Lymphoid Hyperplasia—A Challenging Case Managed Successfully with Methotrexate
by: Gunda Jagruti, et al.
Published: (2025-07-01)

Successful treatment of gastric cancer after complete response of lung cancer by nivolumab: a case report
by: Shunji Endo, et al.
Published: (2020-10-01)

Effects of Metformin on Survival and Toxicity in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab
by: Heves Surmeli, et al.
Published: (2025-06-01)

A Case of PMR‐Like irAE Developing After Treatment With Ipilimumab and Nivolumab for Lung Cancer
by: Ryuichi Utsumi, et al.
Published: (2025-06-01)

Combination of concurrent targeted and immune-therapy with nivolumab and cetuximab: new perspectives for squamous cell carcinoma treatment
by: A. M. Mudunov, et al.
Published: (2020-11-01)

Randomized phase II study of consolidation immunotherapy with nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small-cell lung cancer (NSCLC): Big Ten Cancer Research Consortium LUN16-081
by: Borys Hrinczenko, et al.
Published: (2025-07-01)

Retreatment With Nivolumab and Ipilimumab in Pleural Mesothelioma Following Disease Progression After a Durable Response: Case Series
by: Illaa Smesseim, MD, et al.
Published: (2025-07-01)

Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab
by: Tsutomu Namikawa, et al.
Published: (2018-07-01)

Nivolumab-containing therapy in patients with newly diagnosed classical Hodgkin lymphoma: own clinical observations and literature review
by: D. D. Ivanova, et al.
Published: (2024-12-01)

Incidence of phototherapy-induced hypocalcemia in neonates with hyperbilirubinemia
by: Mazhar Khan, et al.
Published: (2025-03-01)

Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study
by: Maria T. Bourlon, et al.
Published: (2025-07-01)

Hypercalcemia as an Immune-Related Adverse Event in a Patient Receiving Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report
by: Sam Plessers, et al.
Published: (2025-01-01)

Multimodal therapy with surgery and adjuvant nivolumab for late-onset multiple liver metastases of choroidal malignant melanoma: a case report
by: Ryuta Muraki, et al.
Published: (2020-07-01)